Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 1473 | 47.38 |
09:34 ET | 1500 | 47.27 |
09:36 ET | 400 | 47.265 |
09:38 ET | 12603 | 47.49 |
09:39 ET | 2351 | 47.97 |
09:41 ET | 2000 | 48.05 |
09:43 ET | 1150 | 48.3 |
09:45 ET | 2141 | 48.47 |
09:48 ET | 3109 | 48.455 |
09:50 ET | 1200 | 48.57 |
09:52 ET | 3236 | 48.58 |
09:54 ET | 1570 | 48.59 |
09:56 ET | 2350 | 48.55 |
09:57 ET | 3650 | 48.41 |
09:59 ET | 361 | 48.39 |
10:01 ET | 6905 | 48.6 |
10:03 ET | 3755 | 48.8 |
10:06 ET | 2831 | 48.86 |
10:08 ET | 2100 | 48.74 |
10:10 ET | 2300 | 48.84 |
10:12 ET | 1554 | 48.74 |
10:14 ET | 1150 | 48.61 |
10:15 ET | 4879 | 48.52 |
10:17 ET | 3912 | 48.52 |
10:19 ET | 2700 | 48.535 |
10:21 ET | 2729 | 48.545 |
10:24 ET | 6252 | 48.48 |
10:26 ET | 2827 | 48.59 |
10:28 ET | 3437 | 48.63 |
10:30 ET | 500 | 48.575 |
10:32 ET | 600 | 48.565 |
10:33 ET | 5649 | 48.39 |
10:35 ET | 2152 | 48.435 |
10:37 ET | 1870 | 48.57 |
10:39 ET | 13732 | 48.72 |
10:42 ET | 15556 | 48.965 |
10:44 ET | 850 | 49.12 |
10:46 ET | 700 | 49.13 |
10:48 ET | 800 | 49.31 |
10:50 ET | 2503 | 49.32 |
10:51 ET | 11585 | 49.04 |
10:53 ET | 3163 | 49.03 |
10:55 ET | 11628 | 49.095 |
10:57 ET | 1200 | 49.105 |
11:00 ET | 1479 | 49.095 |
11:02 ET | 700 | 49.095 |
11:04 ET | 6150 | 49 |
11:06 ET | 10455 | 49 |
11:08 ET | 19786 | 49.02 |
11:09 ET | 5440 | 48.93 |
11:11 ET | 3326 | 48.99 |
11:13 ET | 1284 | 49.0122 |
11:15 ET | 1318 | 49.02 |
11:18 ET | 1057 | 48.985 |
11:20 ET | 46537 | 49 |
11:22 ET | 3251 | 49.08 |
11:24 ET | 2393 | 49.18 |
11:26 ET | 600 | 49.12 |
11:27 ET | 900 | 49.135 |
11:29 ET | 6214 | 49.21 |
11:31 ET | 1860 | 49.08 |
11:33 ET | 699 | 49.08 |
11:36 ET | 2595 | 49.08 |
11:38 ET | 1743 | 49.04 |
11:40 ET | 1023 | 48.98 |
11:42 ET | 19245 | 49.03 |
11:44 ET | 31168 | 49.03 |
11:45 ET | 4279 | 49.04 |
11:47 ET | 1148 | 49.03 |
11:49 ET | 4863 | 49.1 |
11:51 ET | 1995 | 49.16 |
11:54 ET | 916 | 49.13 |
11:56 ET | 881 | 49.11 |
11:58 ET | 200 | 49.125 |
12:00 ET | 2233 | 49.19 |
12:02 ET | 700 | 49.19 |
12:03 ET | 3283 | 49.34 |
12:05 ET | 2288 | 49.43 |
12:07 ET | 2604 | 49.36 |
12:09 ET | 650 | 49.39 |
12:12 ET | 200 | 49.35 |
12:14 ET | 400 | 49.22 |
12:16 ET | 200 | 49.22 |
12:18 ET | 1278 | 49.1 |
12:20 ET | 11852 | 49.09 |
12:21 ET | 12746 | 49.12 |
12:23 ET | 1216 | 49.09 |
12:25 ET | 822 | 49.06 |
12:27 ET | 206 | 49.06 |
12:30 ET | 300 | 49.06 |
12:32 ET | 2347 | 49.13 |
12:34 ET | 1708 | 49.11 |
12:36 ET | 822 | 49.07 |
12:39 ET | 100 | 49.065 |
12:41 ET | 1327 | 49.05 |
12:43 ET | 1241 | 49 |
12:45 ET | 733 | 49.035 |
12:48 ET | 7605 | 49.405 |
12:50 ET | 1403 | 49.44 |
12:52 ET | 600 | 49.39 |
12:54 ET | 100 | 49.33 |
12:56 ET | 911 | 49.32 |
12:57 ET | 4160 | 49.52 |
12:59 ET | 926 | 49.51 |
01:01 ET | 700 | 49.45 |
01:03 ET | 400 | 49.42 |
01:06 ET | 300 | 49.465 |
01:08 ET | 2058 | 49.375 |
01:10 ET | 3610 | 49.49 |
01:12 ET | 372 | 49.43 |
01:14 ET | 226 | 49.445 |
01:15 ET | 1314 | 49.45 |
01:17 ET | 1474 | 49.475 |
01:19 ET | 1027 | 49.48 |
01:21 ET | 939 | 49.46 |
01:24 ET | 2910 | 49.39 |
01:26 ET | 1918 | 49.53 |
01:28 ET | 220 | 49.6 |
01:30 ET | 2542 | 49.745 |
01:32 ET | 1318 | 49.71 |
01:33 ET | 1228 | 49.71 |
01:35 ET | 911 | 49.705 |
01:37 ET | 1074 | 49.76 |
01:39 ET | 424 | 49.69 |
01:42 ET | 11256 | 49.65 |
01:44 ET | 1765 | 49.74 |
01:46 ET | 121 | 49.74 |
01:48 ET | 817 | 49.755 |
01:50 ET | 823 | 49.8 |
01:51 ET | 315 | 49.835 |
01:53 ET | 600 | 49.83 |
01:55 ET | 620 | 49.81 |
01:57 ET | 2494 | 49.8 |
02:00 ET | 3787 | 49.71 |
02:02 ET | 300 | 49.7 |
02:04 ET | 400 | 49.695 |
02:06 ET | 2132 | 49.69 |
02:08 ET | 1000 | 49.64 |
02:09 ET | 700 | 49.66 |
02:11 ET | 935 | 49.65 |
02:13 ET | 626 | 49.67 |
02:15 ET | 460 | 49.69 |
02:18 ET | 1410 | 49.675 |
02:20 ET | 5045 | 49.77 |
02:22 ET | 1623 | 49.755 |
02:24 ET | 443 | 49.745 |
02:26 ET | 300 | 49.69 |
02:27 ET | 4996 | 49.475 |
02:29 ET | 950 | 49.475 |
02:31 ET | 702 | 49.425 |
02:33 ET | 3595 | 49.45 |
02:36 ET | 453 | 49.445 |
02:38 ET | 222 | 49.455 |
02:40 ET | 400 | 49.42 |
02:42 ET | 200 | 49.43 |
02:44 ET | 500 | 49.465 |
02:45 ET | 897 | 49.43 |
02:47 ET | 1894 | 49.42 |
02:49 ET | 736 | 49.44 |
02:51 ET | 3752 | 49.29 |
02:54 ET | 1373 | 49.225 |
02:56 ET | 2274 | 49.36 |
02:58 ET | 2289 | 49.43 |
03:00 ET | 100 | 49.5 |
03:02 ET | 400 | 49.445 |
03:03 ET | 749 | 49.445 |
03:05 ET | 2075 | 49.39 |
03:07 ET | 2665 | 49.47 |
03:09 ET | 1831 | 49.505 |
03:12 ET | 708 | 49.48 |
03:14 ET | 731 | 49.475 |
03:16 ET | 1069 | 49.46 |
03:18 ET | 560 | 49.47 |
03:20 ET | 3259 | 49.33 |
03:21 ET | 629 | 49.27 |
03:23 ET | 6092 | 49.305 |
03:25 ET | 710 | 49.24 |
03:27 ET | 1661 | 49.3 |
03:30 ET | 8217 | 49.495 |
03:32 ET | 2143 | 49.41 |
03:34 ET | 1139 | 49.37 |
03:36 ET | 4473 | 49.36 |
03:38 ET | 5993 | 49.51 |
03:39 ET | 7311 | 49.46 |
03:41 ET | 2443 | 49.445 |
03:43 ET | 2929 | 49.39 |
03:45 ET | 6535 | 49.315 |
03:48 ET | 3209 | 49.355 |
03:50 ET | 4421 | 49.45 |
03:52 ET | 4988 | 49.355 |
03:54 ET | 7721 | 49.32 |
03:56 ET | 12674 | 49.41 |
03:57 ET | 14189 | 49.32 |
03:59 ET | 104543 | 49.27 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 9.2B | -31.4x | --- |
Ascendis Pharma A/S | 6.9B | -15.0x | --- |
Intra-Cellular Therapies Inc | 8.0B | -84.9x | --- |
Tempus AI Inc | 7.6B | -6.5x | --- |
Insmed Inc | 12.8B | -13.4x | --- |
Viking Therapeutics Inc | 7.4B | -65.7x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.2B |
---|---|
Revenue (TTM) | $456.0M |
Shares Outstanding | 183.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.10 |
EPS | $-1.57 |
Book Value | $6.88 |
P/E Ratio | -31.4x |
Price/Sales (TTM) | 20.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -81.89% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.